6:28 PM
 | 
Jan 15, 2013
 |  BC Extra  |  Financial News

Pacira planning $100M note deal

Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) said it plans to raise $100 million through the sale of convertible senior notes due 2019....

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >